镇痛与复苏：当前研究

出版道德

出版道德标准的存在是为了制作某些高质量的科学出版物、公众对科学发现的信任以及人们的工作和思想得到认可。

镇痛与复苏：当前研究遵循国际医学期刊编辑委员会 (ICMJE) 行为准则和期刊编辑出版道德最佳实践指南。

文章评估

所有手稿均需接受同行评审，并有望达到学术卓越的标准。如果通过编辑接受，提交的内容将由同行评审员考虑，同行评审员的身份将对作者保持匿名。

我们的研究诚信团队偶尔会在标准同行评审之外寻求建议，例如，针对具有严重道德、安全、生物安全或社会影响的提交内容。在决定适当的行动之前，我们可能会咨询专家和学术编辑，包括但不限于招募具有特定专业知识的审稿人、由其他编辑进行评估以及拒绝进一步考虑提交的内容。

抄袭

作者不再需要在没有注明出处的情况下使用他人的文字、数字或想法。所有来源都必须在使用时引用，并且应限制措辞的重复使用，并在文本中注明或引用。

被发现抄袭其他作者手稿的手稿，无论是否已发表，都将被拒绝，作者还可能受到制裁。任何已发表的文章也可能需要更正或撤回。

重复提交和重复发表

镇痛与复苏：当前研究仅考虑原创内容，即之前未发表的文章，包括英语以外的语言。基于先前仅在预印本服务器、机构存储库或论文中公开的内容的文章将被考虑。

提交给本期刊的手稿在审议期间不得提交到其他地方，并且在提交到其他地方之前必须撤回。被发现同时在其他地方提交文章的作者可能会受到制裁。

如果作者使用自己以前发表的作品或目前正在审查的作品作为提交稿件的基础，他们必须引用以前的文章，并指出他们提交的稿件与以前的作品有何不同。在方法之外重复使用作者自己的话应在文本中注明或引用。重复使用作者自己的图表或大量文字可能需要版权所有者的许可，并且作者有责任获得该许可。

镇痛与复苏：当前研究将考虑在会议上发表的文章的扩展版本，前提是在求职信中声明这一点，明确引用和讨论以前的版本，有重要的新内容，并获得任何必要的许可。

重复发表，即不恰当地将研究结果划分为多篇文章，可能会导致拒绝或要求合并提交的手稿，以及对已发表文章的更正。重复发表相同或非常相似的文章可能会导致后一篇文章被撤回，并且作者可能会受到制裁。

引文操纵

如果作者发现其提交的手稿包含主要目的是增加对特定作者的作品或特定期刊上发表的文章的引用次数，则可能会受到制裁。

编辑和审稿人不得仅仅为了增加期刊或与之相关的其他期刊对自己或同事的作品的引用而要求作者添加参考文献。

捏造和伪造

提交的手稿或发表的文章的作者被发现捏造或伪造结果，包括操纵图像，可能会受到制裁，发表的文章可能会被撤回。

作者身份和致谢

所有列出的作者必须对手稿中的研究做出重大科学贡献，批准其主张，并同意成为作者。列出做出重大科学贡献的每个人非常重要。提交作者必须提供 ORCID，我们鼓励所有作者提供一个。作者身份的变更必须向本期刊声明并得到所有作者的同意。作者可以在已发表的文章上更改姓名（见下文）。

任何对研究或手稿准备做出贡献但不是作者的人都应在获得其许可的情况下予以致谢。

除作者之一之外的任何人提交的内容将不予考虑。

 

利益冲突

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Editor will take reviewer misconduct seriously and pursue any allegation of breach of confidentiality, non-declaration of conflicts of interest (financial or non-financial), inappropriate use of confidential material, or delay of peer review for competitive advantage. Allegations of serious reviewer misconduct, such as plagiarism, will be taken to the institutional level.

Authors

Authors must declare all potential interests in a ‘Conflicts of interest’ section, which should explain why the interest may be a conflict. If there are none, the authors should state “The author declares that there are no conflicts of interest regarding the publication of this paper.” Submitting authors are responsible for co-authors declaring their interests.

Authors must declare current or recent funding (including article processing charges) and other payments, goods or services that might influence the work. All funding, whether a conflict or not, must be declared in the ‘Funding Statement’.

Declared conflicts of interest will be considered by the editor and reviewers and included in the published article.

Author(s) should state that the study they are submitting was approved by the relevant research ethics committee or institutional review board. If human participants were involved, manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and appropriate informed consent of each. If experimental animals were used, the materials and methods (experimental procedures) section must clearly indicate that appropriate measures were taken to minimize pain or discomfort, and details of animal care should be provided.

Editors and Reviewers

Editors and reviewers should decline to be involved with a submission when they

• Have a recent publication or current submission with any author
• Share or recently shared an affiliation with any author
• Collaborate or recently collaborated with any author
• Have a close personal connection to any author
• Have a financial interest in the subject of the work
• Feel unable to be objective

Reviewers must declare any remaining interests in the ‘Confidential’ section of the review form, which will be considered by the editor.

Editors and reviewers must declare if they have previously discussed the manuscript with the authors.

 

Corrections and retractions

When errors are identified in published articles, the publisher will consider what action is required and may consult the editors and the author’s institution(s).

Errors by the authors may be corrected by a corrigendum and errors by the publisher by an erratum.

撤回的论文将在线保留，并且将在所有在线版本（包括 PDF）中显着地标记为撤回，以方便未来的读者。

所有作者将被要求同意该通知的内容。

发表后，将针对期刊发表的文章和任何引用文章进行作者姓名更改，无需提供文件、勘误通知或根据期刊的要求通知任何其他作者。